This Week in Cardiology

• Dec 15 2023 This Week in Cardiology   FDA approves PFA, breakthrough in PAH, residual leaks after percutaneous LAAO, OAC in low-intermediate risk people are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, December 15, 2023
• Dec 08 2023 This Week in Cardiology   Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, December 08, 2023
• Dec 01 2023 This Week in Cardiology   More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 01, 2023
• Nov 17 2023 This Week in Cardiology   An AHA Recap: SELECT, ORBITA2, and ARTESIA are the trials John Mandrola, MD, reviews in this week’s podcast.
  theheart.org on Medscape, November 17, 2023
• Nov 10 2023 This Week in Cardiology   Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 10, 2023
• Nov 03 2023 This Week in Cardiology   Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 03, 2023
• Oct 27 2023 This Week in Cardiology   More on the Million Hearts RCT, ENRICH AF, TAVI vs SAVR, the Partner 3 and Evolut-low-risk trials, and myocardial viability are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, October 27, 2023
• Oct 20 2023 This Week in Cardiology   Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 20, 2023
• Oct 13 2023 This Week in Cardiology   Three stories regarding GLP-1 agonists, imaging during PCI, and the power of sham controls in procedure trials are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, October 13, 2023
• Oct 06 2023 This Week in Cardiology   Coated vs uncoated ASA, a new trial in CAD, conflicts of interest, first AF in the hospital, and changing HTN scoring and CHADSVASC are the topics John Mandrola, MD, covers in this week's podcast.
  theheart.org on Medscape, October 06, 2023
• Sep 29 2023 This Week in Cardiology   Reader feedback, leadless pacing, ABIM, SGLT2 inhibitors, peri-operative MI after cardiac surgery, and AHA late-breakers are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, September 29, 2023
• Sep 22 2023 This Week in Cardiology   Coronary calcium, cardiac arrest survival, Factor XI drug findings, APCs and a potential new board certification in cardiology are the topics discussed by John Mandrola, MD in this week’s podcast.
  theheart.org on Medscape, September 22, 2023
• Sep 15 2023 This Week in Cardiology   Reader feedback, imaging in the cath lab, AF ablation to relieve anxiety, and some possible help in hypertension are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, September 15, 2023
• Sep 08 2023 This Week in Cardiology   ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 08, 2023
• Sep 01 2023 This Week in Cardiology   ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, September 01, 2023
• Aug 25 2023 This Week in Cardiology   GLP-1 agonists in HFpEF, DOACs for subclinical AF, renal denervation, and the matter of remaining in the profession are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, August 25, 2023
• Aug 18 2023 This Week in Cardiology   ICD generator change, less is more in VT management, co-morbidity in HF, and SGLT2i after AF ablation are the topics discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, August 18, 2023
• Aug 11 2023 This Week in Cardiology   Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, August 11, 2023
• Aug 04 2023 This Week in Cardiology   Listener feedback re observational studies, surgeons’ dissent from recent guidelines, aspirin for primary prevention, and fish oil are the topics discussed by John Mandrola.MD in this week's podcast.
  theheart.org on Medscape, August 04, 2023
• Jul 28 2023 This Week in Cardiology   Antiarrhythmic drugs in patients with CAD, observational studies, GLP-1 agonists, and the subcutaneous ICD are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, July 28, 2023